Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2034.00 | 1754.88 | 1.1591 | 1.2295 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1953.00 | 1754.88 | 1.1129 | 1.1638 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1800.00 | 1754.88 | 1.0257 | 1.0377 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1881.00 | 1754.88 | 1.0719 | 1.1048 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2048.00 | 1754.88 | 1.1670 | 1.2408 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2053.00 | 1754.88 | 1.1699 | 1.2448 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1644.00 | 1754.88 | 0.9368 | 0.9062 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 684.27 | 1701.00 | 1754.88 | 0.9693 | 0.9546 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1167.00 | 1754.88 | 0.6650 | 0.4813 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 684.27 | 542.00 | 1754.88 | 0.3089 | -0.1576 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1671.00 | 1754.88 | 0.9522 | 0.9292 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1594.00 | 1754.88 | 0.9083 | 0.8634 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 1250.00 | 684.27 | 1633.00 | 1754.88 | 0.9306 | 0.8968 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1532.00 | 1754.88 | 0.8730 | 0.8097 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1780.00 | 1754.88 | 1.0143 | 1.0210 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 758.00 | 1754.88 | 0.4319 | 0.0782 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 2124.00 | 1754.88 | 1.2103 | 1.3017 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1120.00 | 1754.88 | 0.6382 | 0.4371 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1462.00 | 1754.88 | 0.8331 | 0.7485 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 684.27 | 1906.00 | 1754.88 | 1.0861 | 1.1254 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2087.00 | 1754.88 | 1.1893 | 1.2721 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 2149.00 | 1754.88 | 1.2246 | 1.3216 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 684.27 | 2183.00 | 1754.88 | 1.2440 | 1.3486 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 684.27 | 981.00 | 1754.88 | 0.5590 | 0.3036 |
| BT-20 | Linsitinib | 10 | uM | 9 | 1250.00 | 684.27 | 1276.00 | 1754.88 | 0.7271 | 0.5819 |